Eastern Bank Reduces Stock Holdings in Intuitive Surgical, Inc. $ISRG

Eastern Bank cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 3,735 shares of the medical equipment provider’s stock after selling 1,740 shares during the quarter. Eastern Bank’s holdings in Intuitive Surgical were worth $1,670,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Tobam lifted its holdings in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $27,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. Riggs Asset Managment Co. Inc. lifted its stake in Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares in the last quarter. Finally, First Command Advisory Services Inc. grew its holdings in Intuitive Surgical by 3,750.0% during the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 75 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Raymond James Financial set a $603.00 target price on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. Finally, Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $622.17.

Intuitive Surgical Trading Down 2.7%

Shares of NASDAQ:ISRG opened at $546.76 on Thursday. The firm has a market cap of $196.00 billion, a price-to-earnings ratio of 72.32, a PEG ratio of 4.57 and a beta of 1.67. The stock’s 50-day moving average price is $566.95 and its two-hundred day moving average price is $512.09. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the firm posted $1.84 EPS. The company’s revenue was up 22.9% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: William Blair reiterated a Buy rating, citing early DV5 adoption, a strong innovation pipeline and a robust multi‑year growth outlook that supports a premium valuation. Intuitive Surgical: DV5 Adoption, Innovation Pipeline, and Robust Growth Outlook Support Premium-Valued Buy Rating
• Neutral Sentiment: Intuitive issued preliminary Q4 and FY‑2025 results and updated guidance showing revenue ahead of Street expectations (preliminary Q4 revenue ~ $2.9B vs. ~$2.7B consensus; FY revenue ~ $10.1B vs. ~$9.9B consensus), which supports near‑term top‑line strength. Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
• Negative Sentiment: Market reaction skewed negative because management’s 2026 da Vinci growth projection disappointed investors — growth for da Vinci placements and procedures did not meet some forecasts, weighing on near‑term sentiment. Intuitive Surgical falls as 2026 da Vinci growth projection misses expectations
• Negative Sentiment: Several market writeups note the stock dropped after the report as investors parsed mixed signals — strong revenue but slower expected device growth and the risk that a high valuation (rich P/E) leaves little room for upside if growth moderates. What’s Going On With Intuitive Surgical Stock Wednesday?
• Negative Sentiment: The international rollout of the da Vinci 5 faces pricing, budget and reimbursement sensitivity that could slow overseas adoption, a potential headwind to multi‑year unit growth if uptake lags outside the U.S. da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?

Insider Activity

In other news, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $496,455.52. The trade was a 83.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the transaction, the insider directly owned 27,027 shares in the company, valued at $14,798,904.12. This trade represents a 51.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.